Pfizer’s Vaccine Offers Strong Protection After First Dose
The Food and Drug Administration’s first analysis of the clinical trial data also found that the coronavirus vaccine worked well regardless of a volunteer’s race, weight or age.
View original article
Contributor: Noah Weiland and Carl Zimmer
